SACRAMENTO, CA / ACCESSWIRE / July 22, 2019 / Falcon Technologies, Inc. (OTC PINK: FLCN), a company focused on the marketing, sale, and distribution of CBD products and other products derived from industrial hemp, announced today it has achieved Pink Sheet Current Information Status at OTC Markets.
The Company also announced it expects to have CBD products available for sale in August 2019.
William Delgado, Chairman and Chief Executive Officer of Falcon Technologies commented, “Over the past few months, Falcon has worked extremely hard to complete and post all our financial statements at OTC markets and to provide all additional paperwork to OTC Markets to achieve Current Information Pink Sheet status.”
Mr. Delgado added, “We expect to have CBD products available for sale in August 2019. Initially, we expected to have products available at an earlier date. However, there have been certain very positive developments that are causing the delay, but these developments are very beneficial for all our shareholders. It is our goal to offer reliable, branded products for consumers and we are working hard to achieve that goal. We expect to deliver additional news to shareholders shortly.”
About Falcon Technologies, Inc. (a/k/a Eco-Growth Strategies, Inc.)
Falcon Technologies, Inc. (a/k/a Eco-Growth Strategies, Inc.) is a nutraceutical company developing a range of CBD-based products. The company’s mission is to employ best practice science to source, manufacture and package all of its CBD products from within the United States. The company performs farm site visits and manufacturing site visits and sources its products from only the highest quality hemp farms and processors in North America. The company also aims to launch a line of CBD products specially formulated for animals by the end of 2019.
The statements made regarding CBD products including our future products have not been evaluated by the Food and Drug Administration. The efficacy of these products and the testimonials made have not been confirmed by FDA- approved research. These products are not intended to diagnose, treat, cure or prevent any disease. All information presented here is not meant as a substitute for or alternative to information from health care practitioners. Please consult your healthcare professional about potential interactions or other possible complications before using any product. The Federal Food, Drug, and Cosmetic Act requires this notice.
SAFE HARBOR ACT
Forward-Looking Statements are included within the meaning of Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements regarding our expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, including words such as “anticipate,” “if,” “believe,” “plan,” “estimate,” “expect,” “intend,” “may,” “could,” “should,” “will,” and other similar expressions are forward-looking statements and involve risks, uncertainties and contingencies, many of which are beyond our control, which may cause actual results, performance, or achievements to differ materially from anticipated results, performance, or achievements. We are under no obligation to (and expressly disclaim any such obligation to) update or alter our forward-looking statements, whether as a result of new information, future events or otherwise.
Contact: William J. Delgado
SOURCE: Falcon Technologies, Inc.
View source version on accesswire.com: